Search

Your search keyword '"Chemotherapy, Adjuvant trends"' showing total 7 results
Start Over Descriptor "Chemotherapy, Adjuvant trends" Language japanese
7 results on '"Chemotherapy, Adjuvant trends"'

1. [Current perspective of treatment for advanced esophageal squamous cell carcinoma].

Author

Hamamoto Y and Kitagawa Y

Subjects
Antineoplastic Combined Chemotherapy Protocols therapeutic use, Chemoradiotherapy, Adjuvant trends, Chemotherapy, Adjuvant trends, Cisplatin administration & dosage, Combined Modality Therapy methods, Combined Modality Therapy trends, Esophagectomy, Fluorouracil administration & dosage, Humans, Multicenter Studies as Topic, Neoadjuvant Therapy trends, Randomized Controlled Trials as Topic, Carcinoma, Squamous Cell therapy, Esophageal Neoplasms therapy
Published
2014

2. [Current status and future perspectives of multimodality treatment for esophageal cancer in Japan].

Author

Ando N

Subjects
Carcinoma, Squamous Cell pathology, Chemoradiotherapy, Adjuvant trends, Chemotherapy, Adjuvant trends, Clinical Trials as Topic, Combined Modality Therapy methods, Combined Modality Therapy trends, Esophageal Neoplasms pathology, Humans, Japan, Neoadjuvant Therapy trends, Neoplasm Staging, Salvage Therapy, Carcinoma, Squamous Cell therapy, Esophageal Neoplasms therapy
Published
2014

3. [Clinical development of chemotherapy for advanced gastric cancer].

Author

Sato A and Matsukawa M

Subjects
Camptothecin administration & dosage, Camptothecin analogs & derivatives, Chemotherapy, Adjuvant trends, Cisplatin administration & dosage, Clinical Trials, Phase III as Topic trends, Docetaxel, Drug Administration Schedule, Drug Combinations, Fluorouracil administration & dosage, Humans, Irinotecan, Neoplasm Staging, Oxonic Acid administration & dosage, Stomach Neoplasms pathology, Taxoids administration & dosage, Tegafur administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Stomach Neoplasms drug therapy
Published
2007

4. [Current status of adjuvant chemotherapy for breast cancer].

Author

Takeuchi H, Okubo K, Fujiuchi N, and Saeki T

Subjects
Anthracyclines administration & dosage, Antibodies, Monoclonal administration & dosage, Antibodies, Monoclonal, Humanized, Breast Neoplasms mortality, Breast Neoplasms surgery, Bridged-Ring Compounds administration & dosage, Chemotherapy, Adjuvant trends, Clinical Trials as Topic, Docetaxel, Dose-Response Relationship, Drug, Female, Humans, Menopause, Tamoxifen administration & dosage, Taxoids administration & dosage, Trastuzumab, Antineoplastic Agents therapeutic use, Breast Neoplasms drug therapy, Perioperative Care methods
Abstract

Breast cancer is one of the most common malignancies among Japanese women. Approximately 40,000 new patients are diagnosed annually. In the USA, however,the mortality from breast cancer has recently been declining. A nationwide screening promotion using mammography, and recent advances in the treatment for early breast cancer have been the main reasons. It was widely accepted that for breast cancer as a systemic disease, appropriate systemic treatment of either chemotherapy and endocrine therapy improved the survival. We describe here the contributions of new agents to the improvement in survival for breast cancer patients and introduced the concept of dose density.

Published
2006

5. [Adjuvant chemotherapy for colorectal carcinoma after curative resection].

Author

Murakami M, Tsukuda K, Ota T, Naito M, and Shimizu N

Subjects
Administration, Oral, Antimetabolites, Antineoplastic administration & dosage, Capecitabine, Chemotherapy, Adjuvant trends, Clinical Trials as Topic, Colorectal Neoplasms genetics, Deoxycytidine administration & dosage, Dihydrouracil Dehydrogenase (NADP) genetics, Evidence-Based Medicine, Fluorouracil administration & dosage, Humans, Leucovorin administration & dosage, Levamisole administration & dosage, Pharmacogenetics, Polymorphism, Genetic, Prognosis, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Colectomy, Colorectal Neoplasms drug therapy, Colorectal Neoplasms surgery, Deoxycytidine analogs & derivatives
Published
2003

6. [Adjuvant chemotherapy for colorectal cancer: Its efficacy and problems].

Author

Imanishi T, Kamigaki T, and Kuroda Y

Subjects
Chemotherapy, Adjuvant trends, Clinical Trials as Topic, Colorectal Neoplasms drug therapy, Evidence-Based Medicine, Fluorouracil administration & dosage, Humans, Leucovorin administration & dosage, Levamisole administration & dosage, Meta-Analysis as Topic, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Colorectal Neoplasms surgery
Published
2003

7. [New trends in neoadjuvant chemoradiotherapy for locally-advanced esophageal cancer: esophagectomy--is it necessary?].

Author

Fujita H, Sueyoshi S, Tanaka T, Toh U, Mine T, Sasahara H, Shirouzu K, Yamana H, Toda Y, and Hayabuchi N

Subjects
Carcinoma, Squamous Cell drug therapy, Carcinoma, Squamous Cell radiotherapy, Carcinoma, Squamous Cell secondary, Chemotherapy, Adjuvant trends, Esophageal Neoplasms drug therapy, Esophageal Neoplasms pathology, Esophageal Neoplasms radiotherapy, Female, Humans, Lymphatic Metastasis, Male, Middle Aged, Radiotherapy, Adjuvant trends, Survival Rate, Carcinoma, Squamous Cell surgery, Esophageal Neoplasms surgery, Esophagectomy, Neoadjuvant Therapy trends
Abstract

In responders to neoadjuvant chemoradiotherapy for locally-advanced esophageal cancer, there was no significant difference in the long-term outcome between patients who underwent esophagectomy and those who did not. Esophagectomy might be unnecessary for patients who achieve a complete response with chemoradiotherapy for an esophageal cancer, in cases when salvage surgery is considered in order to treat any future recurrence.

Published
2000

Catalog

Books, media, physical & digital resources
See catalog results